Suven Life Sciences Ltd. - Research Center
530239 SUVEN Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 21.81 | 21.81 | 14.54 | 12.73 | 12.73 |
| Share application money | - | - | - | 36.92 | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 823.57 | 831.64 | 461.44 | 352.01 | 374.95 |
| Loan funds | |||||
| Secured loans | - | - | 0.48 | 0.39 | 1.08 |
| Unsecured loans | - | - | - | - | - |
| Total | 845.38 | 853.44 | 476.46 | 402.05 | 388.76 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 77.46 | 88.53 | 82.53 | 66.93 | 43.61 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 49.25 | 51.32 | 44.97 | 45.97 | 18.92 |
| Net block | 28.21 | 37.21 | 37.56 | 20.96 | 24.69 |
| Capital work-in-progress | - | - | 3.55 | 4.77 | - |
| Investments | 653.05 | 528.20 | 425.85 | 295.11 | 241.86 |
| Net current assets | |||||
| Current assets, loans & advances | 170.23 | 295.03 | 19.38 | 94.54 | 143.20 |
| Less : current liabilities & provisions | 6.11 | 7.00 | 9.89 | 13.34 | 21.00 |
| Total net current assets | 164.12 | 288.04 | 9.49 | 81.20 | 122.20 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 845.38 | 853.44 | 476.46 | 402.05 | 388.76 |
| Notes: | |||||
| Book value of unquoted investments | 653.05 | 528.20 | 425.85 | 295.11 | 241.86 |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | - | - | - | - | - |
| Number of equity sharesoutstanding (Lacs) | 2180.74 | 2180.74 | 1453.82 | 1272.82 | 1272.82 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis